Prelude Capital Management, LLC Tg Therapeutics, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 57,497 shares of TGTX stock, worth $1.68 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
57,497
Previous 57,497 -0.0%
Holding current value
$1.68 Million
Previous $1.34 Million -0.0%
% of portfolio
0.09%
Previous 0.05%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$17.21 - $25.28 $174,492 - $256,313
-10,139 Reduced 14.99%
57,497 $1.34 Million
Q2 2024

Aug 14, 2024
BUY
$13.32 - $19.19 $160,319 - $230,970
12,036 Added 21.65%
67,636 $1.2 Million
Q1 2024

May 15, 2024
BUY
$13.02 - $21.3 $88,536 - $144,840
6,800 Added 13.93%
55,600 $845,000
Q4 2023

Feb 14, 2024
SELL
$6.68 - $18.81 $66,479 - $187,197
-9,952 Reduced 16.94%
48,800 $833,000
Q3 2023

Nov 14, 2023
BUY
$8.36 - $26.5 $413,234 - $1.31 Million
49,430 Added 530.25%
58,752 $491,000
Q2 2023

Aug 14, 2023
BUY
$15.48 - $35.0 $144,304 - $326,270
9,322 New
9,322 $231,000
Q4 2022

Feb 14, 2023
SELL
$5.01 - $11.83 $4,509 - $10,647
-900 Reduced 2.37%
37,127 $439,000
Q3 2022

Nov 14, 2022
SELL
$4.57 - $8.4 $8,897 - $16,354
-1,947 Reduced 4.87%
38,027 $225,000
Q2 2022

Aug 15, 2022
SELL
$3.74 - $10.66 $6,271 - $17,876
-1,677 Reduced 4.03%
39,974 $170,000
Q1 2022

May 16, 2022
BUY
$7.81 - $20.45 $14,237 - $37,280
1,823 Added 4.58%
41,651 $396,000
Q4 2021

Feb 14, 2022
BUY
$15.2 - $35.51 $12,859 - $30,041
846 Added 2.17%
39,828 $757,000
Q3 2021

Nov 15, 2021
BUY
$21.78 - $40.45 $846,849 - $1.57 Million
38,882 Added 38882.0%
38,982 $1.3 Million
Q3 2019

Nov 14, 2019
BUY
$5.38 - $8.99 $145 - $242
27 Added 36.99%
100 $1,000
Q4 2018

Feb 14, 2019
BUY
$3.44 - $5.76 $251 - $420
73 New
73 $0
Q3 2018

Nov 14, 2018
SELL
$5.15 - $14.0 $401 - $1,092
-78 Closed
0 $0
Q2 2018

Aug 14, 2018
BUY
$12.5 - $15.0 $975 - $1,170
78 New
78 $1,000

Others Institutions Holding TGTX

# of Institutions
336
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email